Q1 FY27 results: Revenue falls 23%, profit plunges 98% YoY
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bafna Pharmaceuticals Q1 FY27: Revenue from operations fell about 23% YoY to about 2658 lakhs from about 3462 lakhs. Profit after tax collapsed to about 8 lakhs from about 339 lakhs a year ago, a drop of nearly 98%. Total income stood at about 2849 lakhs versus about 3522 lakhs. Other income rose sharply to about 191 lakhs while other expenses jumped from 150 to 259 lakhs. The auditor flagged as an emphasis of matter GST demands of about 235 lakhs and GST refund recovery orders of about 331 lakhs; the company says it will contest both. AGM set for September 11, 2026.
Sharp revenue and profit decline; pending GST litigation worth about 560 lakhs is a key overhang and outcome will materially affect the stock.